Association of Carcinoembryonic Antigen Reduction With Progression-free and Overall Survival Improvement in Advanced Non-small-cell Lung Cancer-Reference-Cited by-同舟云学术

Association of Carcinoembryonic Antigen Reduction With Progression-free and Overall Survival Improvement in Advanced Non-small-cell Lung Cancer

Published:2021-11 Issue:6 Volume:22 Page:510-522
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Arrieta Oscar,Varela-Santoyo Edgar,Cardona Andrés F.,Sánchez-Reyes Roberto,Lara-Mejía Luis^ORCID,Bassarmal Suraj Samtani,Valle-Bautista Dafne,Corrales-Rodríguez Luis,Motola-Kuba Daniel,Cabrera-Miranda Luis,Martín Claudio

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference48 articles.

1. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods;Ferlay;Int J Cancer,2019

2. Lung cancer: current therapies and new targeted treatments;Hirsch;Lancet,2017

3. Survivorship in non-small cell lung cancer: challenges faced and steps forward;Vijayvergia;J Natl Compr Canc Netw,2015

4. Barrón-Barrón F., Guzmán-De Alba E., Alatorre-Alexander J., et al. Guía de Práctica Clínica Nacional para el manejo del Cáncer de Pulmón de células no pequeñas en estadios tempranos, localmente avanzados y metastásicos. Salud Publica de Mexico. 2019. 2019; 61 (3, May-Jun):56. doi10.21149/9916.

5. The evolution of imaging in cancer: current state and future challenges;Higgins;Semin Oncol,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of blood-based protein biomarkers in non-small cell lung cancer: A critical review and 2008–2022 update;Tumor Biology;2023-10-28

2. Promising response of dabrafenib, trametinib, and osimertinib combination therapy for concomitant BRAF and EGFR-TKI resistance mutations;Anti-Cancer Drugs;2023-08-15

3. Serum tumor markers for response prediction and monitoring of advanced lung cancer: A review focusing on immunotherapy and targeted therapies;Tumor Biology;2023-05-23

4. A specific sensor system based on in-situ synthesis fluorescent polymers by ARGET ATRP achieving sensitive exosome detection;Talanta;2023-02

5. EGFR/BRAF/MEK co-inhibition for EGFR-mutated lung adenocarcinoma patients with an acquired BRAFV600E mutation: a case report and review of literature;Cancer Drug Resistance;2021